Paclitero – Paclitaxel 260mg Injection
Paclitaxel (Paclitero) Injection – Treatment for Multiple Cancer
PACLITERO 260 MG INJECTION is a cancer therapy that is used to treat breast cancer, pancreatic cancer, and non-small cell lung cancer.
A competent medical expert administers it as an injection. Your doctor will determine the appropriate dose and frequency of administration. This can vary depending on what you are being treated for and may alter over time. You should take it precisely as prescribed by your doctor. Taking it incorrectly or in excess might result in significant negative effects. It may take many weeks or months for you to notice or feel the advantages, but do not stop taking it until your doctor instructs you to do so.
USES OF PACLITAXEL (PACLITERO) 260MG INJECTION
- Breast cancer
- Non-small cell lung cancer
- Pancreatic cancer
WORKS OF PACLITAXEL (PACLITERO) 260MG INJECTION
PACLITERO 260 MG INJECTION is a cancer treatment. It operates by interfering with the microtubule structures that aid in the division and multiplication of cancer cells. This reduces cancer cell proliferation and eventually kills them.
SIDE EFFECTS OF PACLITAXEL (PACLITERO) 260MG INJECTION
- Low blood platelets
- Upper respiratory tract infection
- Urinary tract infection
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy
- Decreased white blood cell count (neutrophils)
WARNING & PRECAUTIONS
PACLITERO 260 MG INJECTION may induce negative effects that impair your driving abilities.
There is no reason why you cannot drive between courses of PACLITERO 260 MG INJECTION, but keep in mind that this drug includes alcohol and it may be unsafe to drive.
In people with renal problems, PACLITERO 260 MG INJECTION is safe to use. There is no need to change the dose of PACLITERO 260 MG INJECTION.
However, if you have any underlying renal problems, see your doctor.
In individuals with liver problems, PACLITERO 260 MG INJECTION should be used with care. PACLITERO 260 MG INJECTION dosage may need to be adjusted. Please visit your physician.
PACLITERO 260 MG INJECTION should not be used in people with severe liver disease.
PACLITERO 260 MG INJECTION should not be used during pregnancy since there is clear evidence of a danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please visit your physician.
PACLITERO 260 MG INJECTION should not be used when nursing. According to the data, the medicine may be hazardous to the infant.
Fedelty Health Care is a Paclitaxel third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.